Kato R, Ross S, Foex P. Fentanyl protects the heart against ischemic injury via opioid receptors: adenosine A1 receptors and KATP channel linked mechanisms in rats [J]. Br J Anaesth,2000, 84(2):204-214.
Zhang Y, Irwin MG,Wong TM.Remifentanil preconditioning protects against ischemic injury in the intact rat heart[J]. Anesthesiology, 2004,101(4):918-923.
[5]
Glass PS,Gan TJ,Howell S.A review of the pharmacokinetics and pharmacodynamics of remifentanil[J]. Anesthanalg, 1999,89(suppl 4):7-14.
Elliott P,O`hare R, Bill KM,et al. Severe cardiovascular depression with remifentanil[J]. Anesthanalg, 2000,91:58-61.
[8]
Mertens MJ, Olofsen E, Engbers FH, et al. Propofol reduces perioperative remifentanil requirements in asynergistic manner response surface modeling of perioperative remifentanil propofol interactions[J]. Anesthesiology, 2003, 99:347-359.
[9]
Chanavaz C, Tirel O, Wodey E, et al. Haemodynamic effects of remifentanil in children with and without intravenous atropine: An echocardiographic study[J]. British Journal of Anaesthesia, 2005,94: 74-79.
[10]
Zhang Y, Irwin MG,Wong TM, et al.Remifentanil preconditioning confers cardioprotection via cardiac δ-and κ-opioid receptors[J]. Anertheriology,2005,102(2):371-378.
[11]
Peart JN, Gross ER, Gress GJ. Opioid2induced preconditioning: recent advances and future perspectives[J]. Vascul Pharmacol,2005,42:211-218.
Lin JC, Apple FS, Murakami MM, et al. Rates of positive cardiac troponin I and crearine kinase MB mass among patients hospitalized for suspected acute coronary sydromes[J]. Clin Chem, 2004,50(2):333-341.
[14]
Zhang Y, Irwin MG, Wong TM, et al. Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors[J]. Anesthesiology, 2005, 102(2): 371-378.
